Honokiol: An effective inhibitor of tumor necrosis factor-α-induced up-regulation of inflammatory cytokine and chemokine production in human synovial fibroblasts

Acta Biochimica et Biophysica Sinica

Volumn 43, Issue 5, 2011, Pages 380-386

  Li, Jie ^a   Shao, Xueting ^a   Wu, Lijuan ^a   Feng, Tingting ^a   Jin, Changzhong ^a   Fang, Meixin ^a   Wu, Nanping ^a   Yao, Hangping ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

honokiol; inflammatory factors; rheumatoid arthritis synovial fibroblasts

Indexed keywords

AUTACOID; BIPHENYL DERIVATIVE; CHEMOKINE; CYTOKINE; HONOKIOL; LIGNAN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; METABOLISM; SYNOVIUM; UPREGULATION; WESTERN BLOTTING;

BIPHENYL COMPOUNDS; BLOTTING, WESTERN; CELLS, CULTURED; CHEMOKINES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INFLAMMATION MEDIATORS; LIGNANS; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 79955395053     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmr027     Document Type: Article

References (31)

1. Neumann E, Lefevre S, Zimmermann B, Gay S and Muller-Ladner U. Rheumatoid arthritis progression mediated by activated synovial fibroblasts. Trends Mol Med 2010, 16: 458-468.
2. Stankovic A, Slavic V, Stamenkovic B, Kamenov B, Bojanovic M and Mitrovic DR. Serum and synovial fluid concentrations of CCL2 (MCP-1) chemokine in patients suffering rheumatoid arthritis and osteoarthritis reflect disease activity. Bratisl Lek Listy 2009, 110: 641-646.
3. McInnes IB and Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 2007, 7: 429-442. (Pubitemid 46834849)
4. Bartok B and Firestein GS. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev 2010, 233: 233-255.
5. Sheu ML, Chiang CK, Tsai KS, Ho FM, Weng TI, Wu HY and Liu SH. Inhibition of NADPH oxidase-related oxidative stress-triggered signaling by honokiol suppresses high glucose-induced human endothelial cell apoptosis. Free Radic Biol Med 2008, 44: 2043-2050.
6. Kim KR, Park KK, Chun KS and Chung WY. Honokiol inhibits the progression of collagen-induced arthritis by reducing levels of pro-inflammatory cytokines and matrix metalloproteinases and blocking oxidative tissue damage. J Pharmacol Sci 2010, 114: 69-78.
7. Kim BH and Cho JY. Anti-inflammatory effect of honokiol is mediated by PI3K/Akt pathway suppression. Acta Pharmacol Sin 2008, 29: 113-122.
8. Yao H, Zhou J, Li D, Wu N, Bader A, Hoxtermann S and Altmeyer P, et al. FK506 enhances triptolide-induced down-regulation of cyclooxygenase- 2, inducible nitric oxide synthase as well as their products PGE2 and NO in TNF-alpha-stimulated synovial fibroblasts from rheumatoid arthritic patients. Eur J Med Res 2005, 10: 110-116. (Pubitemid 40514879)
9. Tang X, Yao K, Zhang L, Yang Y and Yao H. Honokiol inhibits H2O2-induced apoptosis in human lens epithelial cells via inhibition of the mitogen-activated protein kinase and Akt pathways. Eur J Pharmacol 2011, 1: 72-78.
10. Xu H, He Y, Yang X, Liang L, Zhan Z, Ye Y and Lian F, et al. Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappaB and PI3 kinase/ Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes. Rheumatology 2007, 46: 920-926. (Pubitemid 47062496)
11. Morel J, Audo R, Hahne M and Combe B. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol 3-kinase/Akt. J Biol Chem 2005, 280: 15709-15718. (Pubitemid 40616690)
12. Ohori M. ERK inhibitors as a potential new therapy for rheumatoid arthritis. Drug News Perspect 2008, 21: 245-250.
13. Simsek I. TNF inhibitors-new and old agents for rheumatoid arthritis. Bull NYU Hosp Jt Dis 2010, 68: 204-210.
14. Lee SY and Cho JY. Inhibitory effects of honokiol on LPS and PMA-induced cellular responses of macrophages and monocytes. BMB Rep 2009, 42: 574-579.
15. Liou KT, Shen YC, Chen CF, Tsao CM and Tsai SK. Honokiol protects rat brain from focal cerebral ischemia-reperfusion injury by inhibiting neutrophil infiltration and reactive oxygen species production. Brain Res 2003, 992: 159-166.
16. Bang KH, Kim YK, Min BS, Na MK, Rhee YH, Lee JP and Bae KH. Antifungal activity of magnolol and honokiol. Arch Pharm Res 2000, 23: 46-49.
17. Kong ZL, Tzeng SC and Liu YC. Cytotoxic neolignans: an SAR study. Bioorg Med Chem Lett 2005, 15: 163-166.
18. Lin YR, Chen HH, Ko CH and Chan MH. Neuroprotective activity of honokiol and magnolol in cerebellar granule cell damage. Eur J Pharmacol 2006, 537: 64-69.
19. Tse AK, Wan CK, Shen XL, Yang M and Fong WF. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation. Biochem Pharmacol 2005, 70: 1443-1457. (Pubitemid 41483455)
20. Shao XT, Feng L, Gu LJ, Wu LJ, Feng TT, Yang YM and Wu NP, et al. Expression of interleukin-18, IL-18BP, and IL-18R in serum, synovial fluid, and synovial tissue in patients with rheumatoid arthritis. Clin Exp Med 2009, 9: 215-221.
21. Hanada T and Yoshimura A. Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev 2002, 13: 413-421.
22. Cheon H, Yu SJ, Yoo DH, Chae IJ, Song GG and Sohn J. Increased expression of pro-inflammatory cytokines and metalloproteinase-1 by TGF-beta1 in synovial fibroblasts from rheumatoid arthritis and normal individuals. Clin Exp Immunol 2002, 127: 547-552. (Pubitemid 34437829)
23. Nadkarni S, Mauri C and Ehrenstein MR. Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta. J Exp Med 2007, 204: 33-39. (Pubitemid 46148753)
24. Cho ML, Min SY, Chang SH, Kim KW, Heo SB, Lee SH and Park SH, et al. Transforming growth factor beta 1 (TGF-beta1) down-regulates TNF-alpha-induced RANTES production in rheumatoid synovial fibroblasts through NF-kappaB-mediated transcriptional repression. Immunol Lett 2006, 105: 159-166.
25. Cho ML, Yoon BY, Ju JH, Jung YO, Jhun JY, Park MK and Park SH, et al. Expression of CCR2A, an isoform of MCP-1 receptor, is increased by MCP-1, CD40 ligand and TGF-beta in fibroblast like synoviocytes of patients with RA. Exp Mol Med 2007, 39: 499-507.
26. Katrib A, Smith MD, Ahern MJ, Slavotinek J, Stafford L, Cuello C and Bertouch JV, et al. Reduced chemokine and matrix metalloproteinase expression in patients with rheumatoid arthritis achieving remission. J Rheumatol 2003, 30: 10-21. (Pubitemid 36077766)
27. Sato M, Miyazaki T, Nagaya T, Murata Y, Ida N, Maeda K and Seo H. Antioxidants inhibit tumor necrosis factor-alpha mediated stimulation of interleukin-8, monocyte chemoattractant protein-1, and collagenase expression in cultured human synovial cells. J Rheumatol 1996, 23: 432-438. (Pubitemid 26101582)
28. Funakoshi-Tago M, Shimizu T, Tago K, Nakamura M, Itoh H, Sonoda Y and Kasahara T. Celecoxib potently inhibits TNF-alpha-induced nuclear translocation and activation of NF-kappaB. Biochem Pharmacol 2008, 76: 662-671.
29. Hiramitsu T, Yasuda T, Ito H, Shimizu M, Julovi SM, Kakinuma T and Akiyoshi M, et al. Intercellular adhesion molecule-1 mediates the inhibitory effects of hyaluronan on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts via down-regulation of NF-kappaB and p38. Rheumatology 2006, 45: 824-832. (Pubitemid 43985370)
30. Gonlugur U and Efeoglu T. Vascular adhesion and transendothelial migration of eosinophil leukocytes. Cell Tissue Res 2004, 318: 473-482. (Pubitemid 40109937)
31. Yang CM, Luo SF, Hsieh HL, Chi PL, Lin CC, Wu CC and Hsiao LD. Interleukin-1beta induces ICAM-1 expression enhancing leukocyte adhesion in human rheumatoid arthritis synovial fibroblasts: involvement of ERK, JNK, AP-1, and NF-kappaB. J Cell Physiol 2010, 224: 516-526.